NCT00802529 - Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Meniere's Disease

Interventions

DRUG

Methylprednisolone

2 transtympanic injections at interval of two weeks.

DRUG

Gentamicin

2 transtympanic injections at an interval of two weeks. If there is significant hearing loss before second injection, it will be replaced by normal saline in double blinded fashion.

Trial Locations (1)

Unknown

Imperial college Healthcare NHS Trust, London